Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Spyropoulos, Alex C; Ageno, Walter; Albers, Gregory W; Elliott, C Gregory; Halperin, Jonathan L; Hiatt, William R; Maynard, Gregory A; Steg, P Gabriel; Weitz, Jeffrey I; Suh, Eunyoung; Spiro, Theodore E; Barnathan, Elliot S; Raskob, Gary E; MARINER Investigators*; Kuzmanovska, Biljana

doi:10.1056/NEJMoa1805090

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Journal

The New England journal of medicine

Date Issued

2018-09-20

Author(s)

Spyropoulos, Alex C

Ageno, Walter

Albers, Gregory W

Elliott, C Gregory

Halperin, Jonathan L

Hiatt, William R

Maynard, Gregory A

Steg, P Gabriel

Weitz, Jeffrey I

Suh, Eunyoung

Spiro, Theodore E

Barnathan, Elliot S

Raskob, Gary E

MARINER Investigators*

DOI

10.1056/NEJMoa1805090

Abstract

Patients who are hospitalized for medical illness remain at risk for venous thromboembolism after discharge, but the role of extended thromboprophylaxis in the treatment of such patients is a subject of controversy.